{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T10:49:20Z","timestamp":1788518960898,"version":"build-2803163510"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,4,28]]},"DOI":"10.7759\/cureus.38251","type":"journal-article","created":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T11:06:35Z","timestamp":1682679995000},"source":"Crossref","is-referenced-by-count":20,"title":["Antibiotic Resistance and Its Impact on Disease Management"],"prefix":"10.7759","author":[{"given":"Chinmayee A","family":"Nadgir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalia A","family":"Biswas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1128\/MMBR.00016-10","article-title":"Origins and evolution of antibiotic resistance","volume":"74","author":"Davies J","year":"2010","unstructured":"Davies J, Davies D. Origins and evolution of antibiotic resistance. Microbiol Mol Biol Rev. 2010, 74:417-33. 10.1128\/MMBR.00016-10","journal-title":"Microbiol Mol Biol Rev"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.1403","article-title":"A review on antibiotic resistance: alarm bells are ringing","volume":"28","author":"Zaman SB","year":"2017","unstructured":"Zaman SB, Hussain MA, Nye R, Mehta V, Mamun KT, Hossain N. A review on antibiotic resistance: alarm bells are ringing. Cureus. 2017, 28:e1403. 10.7759\/cureus.1403","journal-title":"Cureus"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-021-00649-x","article-title":"Antibiotic resistance in the environment","volume":"20","author":"Larsson DG","year":"2022","unstructured":"Larsson DG, Flach CF. Antibiotic resistance in the environment. Nat Rev Microbiol. 2022, 20:257-69. 10.1038\/s41579-021-00649-x","journal-title":"Nat Rev Microbiol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.771510","article-title":"Antibiotic Resistance: One Health One World Outlook","volume":"11","author":"Aslam B","year":"2021","unstructured":"Aslam B, Khurshid M, Arshad MI, et al.. Antibiotic Resistance: One Health One World Outlook. Front Cell Infect Microbiol. 2021, 11:771510. 10.3389\/fcimb.2021.771510","journal-title":"Front Cell Infect Microbiol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a017863","article-title":"Multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis","volume":"5","author":"Seung KJ","year":"2015","unstructured":"Seung KJ, Keshavjee S, Rich ML. Multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis. Cold Spring Harb Perspect Med. 2015, 5:a017863. 10.1101\/cshperspect.a017863","journal-title":"Cold Spring Harb Perspect Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1128\/microbiolspec.VMBF-0016-2015","article-title":"Mechanisms of antibiotic resistance","volume":"4","author":"Munita JM","year":"2016","unstructured":"Munita JM, Arias CA. Mechanisms of antibiotic resistance. Microbiol Spectr. 2016, 4:10. 10.1128\/microbiolspec.VMBF-0016-2015","journal-title":"Microbiol Spectr"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1093\/femsre\/fux053","article-title":"Environmental factors influencing the development and spread of antibiotic resistance","volume":"42","author":"Bengtsson-Palme J","year":"2018","unstructured":"Bengtsson-Palme J, Kristiansson E, Larsson DG. Environmental factors influencing the development and spread of antibiotic resistance. FEMS Microbiol Rev. 2018, 42:fux053. 10.1093\/femsre\/fux053","journal-title":"FEMS Microbiol Rev"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/mbo3.1197","article-title":"Environmental hotspots for antibiotic resistance genes","volume":"10","author":"Kunhikannan S","year":"2021","unstructured":"Kunhikannan S, Thomas CJ, Franks AE, Mahadevaiah S, Kumar S, Petrovski S. Environmental hotspots for antibiotic resistance genes. Microbiologyopen. 2021, 10:e1197. 10.1002\/mbo3.1197","journal-title":"Microbiologyopen"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2018.07.007","article-title":"Prevalence of antibiotic resistance in helicobacter pylori: a\u00a0systematic review and meta-analysis in World Health Organization regions","volume":"155","author":"Savoldi A","year":"2018","unstructured":"Savoldi A, Carrara E, Graham DY, Conti M, Tacconelli E. Prevalence of antibiotic resistance in helicobacter pylori: a\u00a0systematic review and meta-analysis in World Health Organization regions. Gastroenterology. 2018, 155:1372-1382.e17. 10.1053\/j.gastro.2018.07.007","journal-title":"Gastroenterology"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2002606","article-title":"Macrolide and nonmacrolide resistance with mass azithromycin distribution","volume":"383","author":"Doan T","year":"2020","unstructured":"Doan T, Worden L, Hinterwirth A, et al.. Macrolide and nonmacrolide resistance with mass azithromycin distribution. N Engl J Med. 2020, 383:1941-50. 10.1056\/NEJMoa2002606","journal-title":"N Engl J Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.envpol.2021.117402","article-title":"Distribution of antibiotic resistance genes in the environment","volume":"285","author":"Zhuang M","year":"2021","unstructured":"Zhuang M, Achmon Y, Cao Y, et al.. Distribution of antibiotic resistance genes in the environment. Environ Pollut. 2021, 285:117402. 10.1016\/j.envpol.2021.117402","journal-title":"Environ Pollut"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3390\/molecules23040795","article-title":"Antibiotic use in agriculture and its consequential resistance in environmental sources: potential public health implications","volume":"23","author":"Manyi-Loh C","year":"2018","unstructured":"Manyi-Loh C, Mamphweli S, Meyer E, Okoh A. Antibiotic use in agriculture and its consequential resistance in environmental sources: potential public health implications. Molecules. 2018, 23:795. 10.3390\/molecules23040795","journal-title":"Molecules"},{"key":"ref13","article-title":"The antibiotic resistance crisis: part 1: causes and threats","volume":"40","author":"Ventola CL","year":"2015","unstructured":"Ventola CL. The antibiotic resistance crisis: part 1: causes and threats. P T. 2015, 40:277-83.","journal-title":"P T"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00141-20","article-title":"Mechanisms of drug-induced tolerance in Mycobacterium tuberculosis","volume":"34","author":"Goossens SN","year":"2020","unstructured":"Goossens SN, Sampson SL, Van Rie A. Mechanisms of drug-induced tolerance in Mycobacterium tuberculosis. Clin Microbiol Rev. 2020, 34:e00141-20. 10.1128\/CMR.00141-20","journal-title":"Clin Microbiol Rev"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu572","article-title":"Extensive drug resistance acquired during treatment of multidrug-resistant tuberculosis","volume":"59","author":"Cegielski JP","year":"2014","unstructured":"Cegielski JP, Dalton T, Yagui M, et al.. Extensive drug resistance acquired during treatment of multidrug-resistant tuberculosis. Clin Infect Dis. 2014, 59:1049-63. 10.1093\/cid\/ciu572","journal-title":"Clin Infect Dis"},{"key":"ref16","article-title":"Extensively drug-resistant tuberculosis in India: a review","volume":"136","author":"Michael JS","year":"2012","unstructured":"Michael JS, John TJ. Extensively drug-resistant tuberculosis in India: a review. Indian J Med Res. 2012, 136:599-604.","journal-title":"Indian J Med Res"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2020.01.042","article-title":"MDR\/XDR-TB management of patients and contacts: challenges facing the new decade. The 2020 clinical update by the Global Tuberculosis Network","volume":"92S","author":"Migliori GB","year":"2020","unstructured":"Migliori GB, Tiberi S, Zumla A, et al.. MDR\/XDR-TB management of patients and contacts: challenges facing the new decade. The 2020 clinical update by the Global Tuberculosis Network. Int J Infect Dis. 2020, 92S:S15-25. 10.1016\/j.ijid.2020.01.042","journal-title":"Int J Infect Dis"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.mjafi.2021.05.002","article-title":"Multidrug-resistant tuberculosis in COVID-19: double trouble","volume":"77","author":"Marwah V","year":"2021","unstructured":"Marwah V, Peter DK, Ajai Kumar T, Bhati G, Kumar A. Multidrug-resistant tuberculosis in COVID-19: double trouble. Med J Armed Forces India. 2021, 77:S479-82. 10.1016\/j.mjafi.2021.05.002","journal-title":"Med J Armed Forces India"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.11604\/pamj.supp.2020.35.2.23671","article-title":"The impact of COVID-19 pandemic on medicine security in Africa: Nigeria as a case study","volume":"35","author":"Akande-Sholabi W","year":"2020","unstructured":"Akande-Sholabi W, Adebisi YA. The impact of COVID-19 pandemic on medicine security in Africa: Nigeria as a case study. Pan Afr Med J. 2020, 35:73. 10.11604\/pamj.supp.2020.35.2.23671","journal-title":"Pan Afr Med J"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2020.12.018","article-title":"Antibiotic prescribing in patients with COVID-19: rapid review and meta-analysis","volume":"27","author":"Langford BJ","year":"2021","unstructured":"Langford BJ, So M, Raybardhan S, et al.. Antibiotic prescribing in patients with COVID-19: rapid review and meta-analysis. Clin Microbiol Infect. 2021, 27:520-31. 10.1016\/j.cmi.2020.12.018","journal-title":"Clin Microbiol Infect"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-022-07516-x","article-title":"Decreased survival in children inpatients with COVID-19 and antibiotic prescription","volume":"22","author":"Murillo-Zamora E","year":"2022","unstructured":"Murillo-Zamora E, Trujillo X, Huerta M, R\u00edos-Silva M, Lugo-Radillo A, Mendoza-Cano O. Decreased survival in children inpatients with COVID-19 and antibiotic prescription. BMC Infect Dis. 2022, 22:532. 10.1186\/s12879-022-07516-x","journal-title":"BMC Infect Dis"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.biotechadv.2018.11.013","article-title":"Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and alternative therapeutic strategies","volume":"37","author":"Pang Z","year":"2019","unstructured":"Pang Z, Raudonis R, Glick BR, Lin TJ, Cheng Z. Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and alternative therapeutic strategies. Biotechnol Adv. 2019, 37:177-92. 10.1016\/j.biotechadv.2018.11.013","journal-title":"Biotechnol Adv"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00181-19","article-title":"Antimicrobial resistance in ESKAPE pathogens","volume":"33","author":"De Oliveira DM","year":"2020","unstructured":"De Oliveira DM, Forde BM, Kidd TJ, et al.. Antimicrobial resistance in ESKAPE pathogens. Clin Microbiol Rev. 2020, 33:e00181-19. 10.1128\/CMR.00181-19","journal-title":"Clin Microbiol Rev"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2021.108797","article-title":"Antibiotic resistance in diabetic foot infection: how it changed with COVID-19 pandemic in a tertiary care center","volume":"175","author":"Caruso P","year":"2021","unstructured":"Caruso P, Maiorino MI, Macera M, et al.. Antibiotic resistance in diabetic foot infection: how it changed with COVID-19 pandemic in a tertiary care center. Diabetes Res Clin Pract. 2021, 175:108797. 10.1016\/j.diabres.2021.108797","journal-title":"Diabetes Res Clin Pract"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/7656752","article-title":"Community-acquired urinary tract infection by Escherichia coli in the era of antibiotic resistance","volume":"2018","author":"Lee DS","year":"2018","unstructured":"Lee DS, Lee SJ, Choe HS. Community-acquired urinary tract infection by Escherichia coli in the era of antibiotic resistance. Biomed Res Int. 2018, 2018:7656752. 10.1155\/2018\/7656752","journal-title":"Biomed Res Int"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1111\/cxo.12621","article-title":"Overview of mechanisms of antibiotic resistance in Pseudomonas aeruginosa: an ocular perspective","volume":"101","author":"Subedi D","year":"2018","unstructured":"Subedi D, Vijay AK, Willcox M. Overview of mechanisms of antibiotic resistance in Pseudomonas aeruginosa: an ocular perspective. Clin Exp Optom. 2018, 101:162-71. 10.1111\/cxo.12621","journal-title":"Clin Exp Optom"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.15252\/embr.202051034","article-title":"Antibiotic resistance and persistence-implications for human health and treatment perspectives","volume":"21","author":"Huemer M","year":"2020","unstructured":"Huemer M, Mairpady Shambat S, Brugger SD, Zinkernagel AS. Antibiotic resistance and persistence-implications for human health and treatment perspectives. EMBO Rep. 2020, 21:e51034. 10.15252\/embr.202051034","journal-title":"EMBO Rep"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1186\/s12915-019-0692-y","article-title":"Distinct impact of antibiotics on the gut microbiome and resistome: a longitudinal multicenter cohort study","volume":"17","author":"Willmann M","year":"2019","unstructured":"Willmann M, Vehreschild MJ, Biehl LM, et al.. Distinct impact of antibiotics on the gut microbiome and resistome: a longitudinal multicenter cohort study. BMC Biol. 2019, 17:76. 10.1186\/s12915-019-0692-y","journal-title":"BMC Biol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1128\/microbiolspec.ARBA-0009-2017","article-title":"Antimicrobial resistance: a One Health Perspective","volume":"6","author":"McEwen SA","year":"2018","unstructured":"McEwen SA, Collignon PJ. Antimicrobial resistance: a One Health Perspective. Microbiol Spectr. 2018, 6:10.1128\/microbiolspec.ARBA-0009-2017","journal-title":"Microbiol Spectr"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1021\/acs.chemrev.7b00283","article-title":"Natural products as platforms to overcome antibiotic resistance","volume":"117","author":"Rossiter SE","year":"2017","unstructured":"Rossiter SE, Fletcher MH, Wuest WM. Natural products as platforms to overcome antibiotic resistance. Chem Rev. 2017, 117:12415-74. 10.1021\/acs.chemrev.7b00283","journal-title":"Chem Rev"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1086\/321837","article-title":"Antibiotic resistance: consequences of inaction","volume":"33 Suppl 3","author":"Levy SB","year":"2001","unstructured":"Levy SB. Antibiotic resistance: consequences of inaction. Clin Infect Dis. 2001, 33 Suppl 3:S124-9. 10.1086\/321837","journal-title":"Clin Infect Dis"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1139\/cjm-2019-0309","article-title":"Renaissance of vancomycin: approaches for breaking antibiotic resistance in multidrug-resistant bacteria","volume":"66","author":"M\u00fchlberg E","year":"2020","unstructured":"M\u00fchlberg E, Umst\u00e4tter F, Kleist C, Domhan C, Mier W, Uhl P. Renaissance of vancomycin: approaches for breaking antibiotic resistance in multidrug-resistant bacteria. Can J Microbiol. 2020, 66:11-6. 10.1139\/cjm-2019-0309","journal-title":"Can J Microbiol"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-32127-0","article-title":"Pathogen-selective killing by guanylate-binding proteins as a molecular mechanism leading to inflammasome signaling","volume":"13","author":"Feng S","year":"2022","unstructured":"Feng S, Enosi Tuipulotu D, Pandey A, et al.. Pathogen-selective killing by guanylate-binding proteins as a molecular mechanism leading to inflammasome signaling. Nat Commun. 2022, 13:4395. 10.1038\/s41467-022-32127-0","journal-title":"Nat Commun"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.7860\/JCDR\/2014\/8925.4529","article-title":"Strategies to combat antimicrobial resistance","volume":"8","author":"Uchil RR","year":"2014","unstructured":"Uchil RR, Kohli GS, Katekhaye VM, Swami OC. Strategies to combat antimicrobial resistance. J Clin Diagn Res. 2014, 8:ME01-4. 10.7860\/JCDR\/2014\/8925.4529","journal-title":"J Clin Diagn Res"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.4103\/0253-7613.157109","article-title":"Reversing resistance: the next generation antibacterials","volume":"47","author":"Shah NJ","year":"2015","unstructured":"Shah NJ. Reversing resistance: the next generation antibacterials. Indian J Pharmacol. 2015, 47:248-55. 10.4103\/0253-7613.157109","journal-title":"Indian J Pharmacol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/116592-antibiotic-resistance-and-its-impact-on-disease-management","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T14:56:40Z","timestamp":1707490600000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/116592-antibiotic-resistance-and-its-impact-on-disease-management"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,28]]},"references-count":35,"URL":"https:\/\/doi.org\/10.7759\/cureus.38251","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4,28]]}}}